Francesco Costantini Mesquita
YOU?
Author Swipe
View article: Management of Adverse Effects in Testosterone Replacement Therapy
Management of Adverse Effects in Testosterone Replacement Therapy Open
Purpose: This narrative review aims to provide the most updated knowledge regarding the treatment of adverse effects secondary to testosterone replacement therapy (TRT), such as gynecomastia, cardiovascular and hematologic risks, prostate …
View article: Evidence of restorative therapies in the treatment of Peyronie disease: A narrative review
Evidence of restorative therapies in the treatment of Peyronie disease: A narrative review Open
Restorative therapies has emerged as an innovative treatment option for PD and the results from current studies appear to be promising and demonstrated good safety profile. Unfortunately, due to scarce evidence, PRP and SCT are still consi…
View article: Can we improve time to patency with vasoepididymostomy with an innovative epididymal occlusion stitch?
Can we improve time to patency with vasoepididymostomy with an innovative epididymal occlusion stitch? Open
In conclusion, this video is both a demonstration and a call to action for commitment to surgical innovation. We aim to raise the bar in VE success rates, ultimately bringing tangible benefits to patients and contributing to the ongoing ev…
View article: Vas deferens to rete testis anastomosis for obstructive azoospermia
Vas deferens to rete testis anastomosis for obstructive azoospermia Open
Anastomosis from vas deferens to rete testis emerges as a viable surgical reconstruction alternative for obstructive azoospermia, particularly when confronted with non-dilated tubules within the epididymis.
View article: (107) A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO EVALUATE SAFETY AND EFFICACY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE’S DISEASE: CLINICAL TRIAL UPDATE
(107) A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO EVALUATE SAFETY AND EFFICACY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE’S DISEASE: CLINICAL TRIAL UPDATE Open
Introduction Peyronie’s Disease (PD) is a medical condition characterized by localized inflammation in the penile tunica albuginea, leading to the formation of fibrotic plaques. These plaques cause penile curvature and painful erections, s…
View article: (116) COMBINED SHOCKWAVE THERAPY AND PLATELET-RICH PLASMA (COCKTAIL) FOR ERECTILE DYSFUNCTION–A PHASE II TRIAL EMPHASIZING SAFETY AND EFFICACY
(116) COMBINED SHOCKWAVE THERAPY AND PLATELET-RICH PLASMA (COCKTAIL) FOR ERECTILE DYSFUNCTION–A PHASE II TRIAL EMPHASIZING SAFETY AND EFFICACY Open
Introduction Therapeutic approaches focusing on tissue neovascularization play a crucial role in the development of treatments for erectile dysfunction (ED). Autologous Platelet-Rich Plasma (PRP) and Low-Intensity Shockwave Therapy (SWT) a…
View article: (054) CAN WE IMPROVE TIME TO PATENCY WITH VASOEPIDIDYMOSTOMY WITH AN INNOVATIVE EPIDIDYMAL OCCLUSION STITCH?
(054) CAN WE IMPROVE TIME TO PATENCY WITH VASOEPIDIDYMOSTOMY WITH AN INNOVATIVE EPIDIDYMAL OCCLUSION STITCH? Open
Introduction Obstructive azoospermia, affecting 40% of azoospermia cases, occurs when a blockage in the male reproductive tract leads to no sperm in the ejaculate. Blockages may be congenital or acquired, affecting the epididymis, vas defe…
View article: Low-dose prednisone is an effective rescue for deteriorating semen parameters following vasovasostomy
Low-dose prednisone is an effective rescue for deteriorating semen parameters following vasovasostomy Open
Low-dose prednisone therapy appears to be a safe and effective intervention for managing deteriorating semen parameters following VV. The observed improvements in TMSC suggest the potential of prednisone to rescue patients with delayed fai…